April

April 23, 2014

Tumorigenesis: The neem oil component oleic acid suppresses the expression of tumor suppressor TPM1 via up regulation of its target gene, 23/April/2014, 5.56 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Tumorigenesis: The neem oil component oleic acid  suppresses the expression of tumor suppressor TPM1 via […]
April 23, 2014

Elucidating the mechanism of Cajal-Retzius cell differentiation: The miRNA-associated gene product Lin-28 regulates Cajal-Retzius cell differentiation by increasing Foxg1 expression, 23/April/2014, 5,41 am

Prof. Dr. Michlewski G and co-workers from University of Edinburgh, King’s Buildings, Edinburgh EH9 3JR, UK had reported in the prestigious journal Nat Commun. (April 11, 2014) that “Lin28a regulates neuronal differentiation and controls miR-9 […]
April 22, 2014

Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, increases the expression of tumor suppressor Sprouty Homolog 1 via down regulation of its target gene, 23/April/2014, 5.14 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, increases the expression  of […]
April 22, 2014

Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression of tumor suppressor Sprouty Homolog 1 via down regulation of its target gene, 23/April/2014, 5,03 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression […]